These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 30980360)

  • 21. Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids.
    Zielke C; Nielsen JE; Lin JS; Barron AE
    Biophys J; 2024 Jun; 123(11):1316-1328. PubMed ID: 37919905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae.
    Kiattiburut W; Zhi R; Lee SG; Foo AC; Hickling DR; Keillor JW; Goto NK; Li W; Conlan W; Angel JB; Wang G; Tanphaichitr N
    Hum Reprod; 2018 Dec; 33(12):2175-2183. PubMed ID: 30357408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
    Tjabringa GS; Rabe KF; Hiemstra PS
    Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites.
    Rico-Mata R; De Leon-Rodriguez LM; Avila EE
    Exp Parasitol; 2013 Mar; 133(3):300-6. PubMed ID: 23274811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37.
    Zhang Y; Lakshmaiah Narayana J; Wu Q; Dang X; Wang G
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LL-37 domain: A clue to cathelicidin immunomodulatory response?
    Leite ML; Duque HM; Rodrigues GR; da Cunha NB; Franco OL
    Peptides; 2023 Jul; 165():171011. PubMed ID: 37068711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
    Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
    Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cathelicidin LL-37 prevents bacterial biofilm formation.
    Jacobsen AS; Jenssen H
    Future Med Chem; 2012 Aug; 4(12):1587-99. PubMed ID: 22917247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydial-Secreted Protease Chlamydia High Temperature Requirement Protein A (cHtrA) Degrades Human Cathelicidin LL-37 and Suppresses Its Anti-Chlamydial Activity.
    Dong X; Zhang W; Hou J; Ma M; Zhu C; Wang H; Hou S
    Med Sci Monit; 2020 Jul; 26():e923909. PubMed ID: 32634134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo.
    Hou M; Zhang N; Yang J; Meng X; Yang R; Li J; Sun T
    Cell Physiol Biochem; 2013; 32(3):614-23. PubMed ID: 24021961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.
    Iacob SA; Iacob DG
    Protein Pept Lett; 2014; 21(12):1247-56. PubMed ID: 25101632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives for clinical use of engineered human host defense antimicrobial peptides.
    Pachón-Ibáñez ME; Smani Y; Pachón J; Sánchez-Céspedes J
    FEMS Microbiol Rev; 2017 May; 41(3):323-342. PubMed ID: 28521337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration.
    Findlay F; Pohl J; Svoboda P; Shakamuri P; McLean K; Inglis NF; Proudfoot L; Barlow PG
    J Immunol; 2017 Oct; 199(7):2483-2490. PubMed ID: 28814602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanofiber Dressings Topically Delivering Molecularly Engineered Human Cathelicidin Peptides for the Treatment of Biofilms in Chronic Wounds.
    Su Y; Wang H; Mishra B; Lakshmaiah Narayana J; Jiang J; Reilly DA; Hollins RR; Carlson MA; Wang G; Xie J
    Mol Pharm; 2019 May; 16(5):2011-2020. PubMed ID: 30916573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity.
    Bryzek D; Golda A; Budziaszek J; Kowalczyk D; Wong A; Bielecka E; Shakamuri P; Svoboda P; Pohl J; Potempa J; Koziel J
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cathelicidin deficiency predisposes to eczema herpeticum.
    Howell MD; Wollenberg A; Gallo RL; Flaig M; Streib JE; Wong C; Pavicic T; Boguniewicz M; Leung DY
    J Allergy Clin Immunol; 2006 Apr; 117(4):836-41. PubMed ID: 16630942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.
    Wang Y; Hong J; Liu X; Yang H; Liu R; Wu J; Wang A; Lin D; Lai R
    PLoS One; 2008 Sep; 3(9):e3217. PubMed ID: 18795096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.
    Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of Ll-CATH: a novel cathelicidin from the Chong'an Moustache Toad (Leptobrachium liui) with antibacterial and immunomodulatory activity.
    Chen J; Zhang CY; Wang Y; Zhang L; Seah RWX; Ma L; Ding GH
    BMC Vet Res; 2024 Aug; 20(1):343. PubMed ID: 39095814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation.
    Wang Y; Walter G; Herting E; Agerberth B; Johansson J
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2097-100. PubMed ID: 15155206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.